COVID Resource Center Newsroom

Dr. Mills’ experience working with live cell bio-assays propelled him to centerstage in Mayo Clinic’s pursuit of a test to neutralize COVID-19 antibodies and aid in the development of therapies derived from COVID-19 patients' donated plasma.

On April 6, 2020, months of nonstop work for Dr. Theel and her team culminated when Mayo Clinic’s first COVID-19 antibody test — the first commercial antibody test in the nation — was implemented.

Dr. Binnicker's experience developing Mayo Clinic's first diagnostic COVID-19 test was recently featured in Mayo Clinic Alumni magazine.

Thank you to our staff at Mayo Clinic who step up daily during this time of need to provide access to testing during the global pandemic. We appreciate each one of you and all the sacrifices you personally have made throughout this past year.

In an article in The Globe and Mail, Matthew Binnicker, Ph.D., discussed factors that could be contributing to the recent drop in case counts.

In an article exploring the low prevalence of flu cases, Dr. Binnicker was among the experts consulted on why influenza is so scarce this year.

Jane Hermansen of Mayo Clinic Labs weighs in on a discussion of uses for expanded testing capacity after the pandemic is over.

An article authored by Jane Hermansen of Mayo Clinic Labs considers how the experiences of the pandemic will shape the lab industry in years to come.

Being able to identify SARS-CoV-2 in tissue is key to better understand the virus that causes COVID-19. Now, a first-of-its-kind test that detects SARS-CoV-2 in formalin-fixed, paraffin-embedded tissue is available from Mayo Clinic Laboratories.

Viral online posts claimed the World Health Organization changed its COVID-19 testing guidelines and admitted to inflating case counts. Dr. Binnicker helps explain why those claims are false.

Mayo Clinic Laboratories now offers multiplex testing for SARS-CoV-2 (the virus that causes COVID-19) and influenza A and B to all health care providers. This test is used to detect and differentiate between COVID-19 and influenza A and B in a single test using upper respiratory tract specimens.

At the beginning of the pandemic, pooled testing was seen as a way to potentially conserve valuable testing resources, but logistical hurdles and other challenges have limited its usefulness.

Beginning Jan. 26, all air travelers entering the U.S. from other countries will need a negative COVID-19 test result before they can board their flights.